A novel approach to treating osteoarthrosis as a chronic inflammatory disease
A large role in the pathogenesis of osteoarthrosis (OA) is assigned to proinflammatory cytokines, such as interleukin 1 (IL1) and tumor necrosis factor-α, which activate catabolic processes in the cartilaginous tissue and subchondral bone. Diacerein is a medication that is able to block IL1 receptor...
Main Author: | Rimma Mikhailovna Balabanova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2013-06-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/488 |
Similar Items
-
Osteoarthrosis or osteoarthritis? A current view of the disease and its treatment
by: Rimma Mikhailovna Balabanova
Published: (2013-10-01) -
ROLE OF INTERLEUKIN-1 IN OSTEOARTHROSIS AND POSSIBILITIES OF ITS ARREST
by: Rimma Mikhaylovna Balabanova, et al.
Published: (2011-03-01) -
A new view of the therapy of osteoarthrosis
by: T A Raskina, et al.
Published: (2012-12-01) -
Use of diacerein for the treatment of large joint osteoarthritis (A review of literature and the author’s own experience)
by: Rimma Mikhailovna Balabanova
Published: (2015-09-01) -
Role of immune inflammation in the pathogenesis of osteoarthrosis and possibilities of correction of immune impairments
by: R M Balabanova
Published: (2011-12-01)